Merck (MRK) Tops Q1 EPS by 5c; Offers FY23 Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $135.84 +0.21%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q1 EPS of $1.40, $0.05 better than the analyst estimate of $1.35. Revenue for the quarter came in at $0 versus the consensus estimate of $13.78 billion.
GUIDANCE:
Merck sees FY2023 EPS of $6.88-$7.00, versus the consensus of $6.91. Merck sees FY2023 revenue of $57.7-58.9 billion, versus the consensus of $58.3 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
